TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-12-04
公報種別公開国際商標公報
国際登録番号1812649
国際登録日2024-08-23
区分第5類(薬剤),第42類(科学・技術)
商品役務Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use.,Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research全 22 件を表示, experimentation, development, and analysis; advice, information and assistance relating to the foregoing.
基礎出願番号019002624
基礎出願日2024-03-21
基礎出願国EM
出願人Nordic Bioscience A/S
OCRテキストnordicEndotrophin
OCRテキスト2nordicEndotrophin
OCRについて
この商標をJ-PlatPatで参照する

関連商標

Biohaven Therapeutics Ltd.
REJUTRIA
1か月前
Huang, Ke
18日前
MAFRA GROUP S.r.l.
MANIAC LINE
1か月前
ZEALAND PHARMA A/S
2か月前
NODCURE INC.
nBiome
21日前
OCuSOFT INC.
OUST
21日前
F. Hoffmann-La Roche AG
IKRASKO
21日前
Stratpharma AG
COLSIGEN
21日前
METAVIA INC.
METAVIA
21日前
CENTARIX BIOTECH LTD.
Centa
21日前
European Foundation for the care of newborn infants (EFCNI)
18日前
Shenzhen Wandao Cell Technology Co., Ltd.
WonderCel THERAPEUTICS
21日前
MR. KARAN AGRAWAL, MR. LALIT AGRAWAL, MR.GHANSHYAM KUMAR ALL ARE PARTNERS OF Om Shiva Products Inc.
VITO
21日前
F. Hoffmann-La Roche AG
REMRASGY
21日前
FAMILLE MICHAUD APICULTEURS
BEELIZ
21日前
Developing Countries Vaccine Manufactures Network
Developing Countries Vaccine 8 InternationalManufacturers
21日前
Dong-A Pharmaceutical Co., Ltd.
18日前
BEIJING INNO MEDICINE CO., LTD.
18日前
Shanghai Qianzhi Care Products Co., Ltd.
18日前
Developing Countries Vaccine Manufactures Network
DCVMN INTERNATIONAL DevelopingCountriesVaccine ManufacturersNetworkInternational WECONNECTTOPROTECT!
21日前
Lycored Ltd.
18日前
HansolBio
18日前
Natmedics GmbH
18日前
Soho Flordis International Pty Ltd
18日前
Samyang Holdings Corporation
18日前
Zomedica Corp.
18日前
GentiBio, Inc.
18日前
Glaxo Group Limited
18日前
Annexon, Inc.
18日前
Annexon, Inc.
18日前
ADM Protexin Limited
18日前
Developing Countries Vaccine Manufactures Network
21日前
F. Hoffmann-La Roche AG
IMRASGO
21日前
F. Hoffmann-La Roche AG
SUNFENVO
21日前
個人
1か月前
Dyne Therapeutics, Inc.
1か月前
続きを見る